Korean company behind retina-based CVD risk AI plans to go public
Mediwhale has recently raised $13 million in Series C funding, which will also support its entry into the United States market.
Read More from the Global Wellness News ™
Korean company behind retina-based CVD risk AI plans to go public
Mediwhale has recently raised $13 million in Series C funding, which will also support its entry into the United States market.
Read More from the Global Wellness News ™